Astrana Health, Inc. (NASDAQ:ASTH) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Analysts give Astrana Health a consensus "Moderate Buy" from nine covering the stock (six buys, two holds, one sell) with an average 1‑year price target of about $34.86.
• The company posted a solid quarter, reporting $0.54 EPS versus $0.15 expected and $950.5M in revenue (vs. $930.5M est.), with revenue up 42.9% year‑over‑year.
• Institutional investors own about 52.77% of the shares; the stock trades around $29.23 with a $1.63B market cap, a P/E of 63.54, and a 52‑week range of $18.08–$34.80.

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $34.8571.

Several equities research analysts recently issued reports on ASTH shares. BTIG Research cut their price objective on shares of Astrana Health from $45.00 to $40.00 and set a "buy" rating for the company in a research report on Monday, February 2nd. Robert W. Baird lifted their target price on shares of Astrana Health from $37.00 to $40.00 and gave the stock an "outperform" rating in a research note on Wednesday. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Astrana Health in a research note on Monday, December 29th. Truist Financial lifted their target price on shares of Astrana Health from $37.00 to $38.00 and gave the stock a "buy" rating in a research note on Friday, March 13th. Finally, Zacks Research raised shares of Astrana Health from a "strong sell" rating to a "hold" rating in a research note on Wednesday, March 11th.

Hedge Funds Weigh In On Astrana Health

A number of institutional investors have recently bought and sold shares of ASTH. Royal Bank of Canada raised its stake in Astrana Health by 6.5% during the first quarter. Royal Bank of Canada now owns 278,619 shares of the company's stock worth $8,640,000 after purchasing an additional 17,028 shares during the period. AQR Capital Management LLC purchased a new position in Astrana Health during the first quarter worth about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company's stock worth $799,000 after purchasing an additional 1,263 shares during the period. Jones Financial Companies Lllp raised its stake in Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company's stock worth $346,000 after purchasing an additional 10,913 shares during the period. Finally, Intech Investment Management LLC increased its position in shares of Astrana Health by 5.8% during the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company's stock valued at $1,383,000 after acquiring an additional 2,462 shares during the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Price Performance

Shares of NASDAQ ASTH opened at $29.23 on Thursday. The firm has a 50-day simple moving average of $23.42 and a 200-day simple moving average of $25.31. The stock has a market capitalization of $1.63 billion, a price-to-earnings ratio of 63.54 and a beta of 0.77. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.25. Astrana Health has a 52 week low of $18.08 and a 52 week high of $34.80.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.39. The business had revenue of $950.53 million during the quarter, compared to analysts' expectations of $930.46 million. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The company's quarterly revenue was up 42.9% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.15) earnings per share. On average, equities analysts predict that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.